Literature DB >> 3011671

Effect of sublethal gamma radiation on host defenses in experimental scrub typhus.

D J Kelly, J C Rees.   

Abstract

The effect of sublethal gamma radiation on inbred mice chronically infected with scrub typhus rickettsiae was examined. Inbred mice which were inoculated with the Gilliam or Karp strain of Rickettsia tsutsugamushi by the subcutaneous route harbored the infection for at least 1 year. Irradiation of these animals at 12 or 52 weeks postinoculation with normally sublethal levels induced a significantly higher percentage of rickettsemic mice (recrudescence) than was seen in the unirradiated, similarly infected control animals. In addition, sublethal irradiation at 12 weeks induced a quantitative increase in total rickettsiae. Homologous antibody titers to the rickettsiae were examined for 5 weeks after irradiation to determine the role of the humoral response in radiation-induced recrudescence. Unirradiated, infected mice showed consistent titers of about 320 throughout the 5-week observation period, and the titer was not affected by exposure of up to 500 rads of gamma radiation. Drug dose-dependent radioprotection and modification of recrudescence was noted in infected, irradiated mice treated with the antiradiation compound S-2-(3-aminopropylamino)ethyl phosphorothioic acid. The results of this investigation supported the conclusion that the recrudescence of a chronic rickettsial infection in the appropriate host after immunological impairment due to gamma radiation can result in an acute, possibly lethal rickettsemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011671      PMCID: PMC260917          DOI: 10.1128/iai.52.3.718-724.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  The radiosensitivity of T and B lymphocytes in mice.

Authors:  Y Kataoka; T Sado
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

Review 2.  Ionizing radiation and the immune response.

Authors:  R E Anderson; N L Warner
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

3.  Mode of action of some substances which protect against the lethal effects of x-rays.

Authors:  P ALEXANDER; Z M BACQ; S F COUSENS; M FOX; A HERVE; J LAZAR
Journal:  Radiat Res       Date:  1955-06       Impact factor: 2.841

4.  Different allotypic susceptibility of mice to Rickett-sia tsutsugamushi.

Authors:  N G Kekcheeva; I N Kokorin
Journal:  Acta Virol       Date:  1976-04       Impact factor: 1.162

5.  Improvement of lung tumor radiotherapy through differential chemoprotection of normal and tumor tissue.

Authors:  J M Yuhas
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

6.  Plaque assay and cloning of scrub typhus rickettsiae in irradiated L-929 cells.

Authors:  S C Oaks; J V Osterman; F M Hetrick
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

7.  Host defenses in experimental scrub typhus: role of cellular immunity in heterologous protection.

Authors:  A Shirai; P J Catanzaro; S M Phillips; J V Osterman
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

8.  Microimmunofluorescence test for the serological study of rocky mountain spotted fever and typhus.

Authors:  R N Philip; E A Casper; R A Ormsbee; M G Peacock; W Burgdorfer
Journal:  J Clin Microbiol       Date:  1976-01       Impact factor: 5.948

9.  Host defenses in experimental scrub typhus: histopathological correlates.

Authors:  P J Catanzaro; A Shirai; P K Hilderbrandt; J V Osterman
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

10.  Host defenses in experimental scrub typhus: genetics of natural resistance to infection.

Authors:  M G Groves; J V Osterman
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  1 in total

1.  Characterization of factors determining Rickettsia tsutsugamushi pathogenicity for mice.

Authors:  M G Groves; D J Kelly
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.